U.S. stock futures weaken; M&A in focus

U.S. stock futures point south, with weaker European markets in the background and Genzyme in focus after Sanofi goes hostile with its bid.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.